| | 1370651-20-9 Basic information More.. |
| Product Name: | Ensartinib (X-396) | | Synonyms: | 561.44;C26H27Cl2FN6O3;3-Pyridazinecarboxamide, 6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[4-[[(3R,5S)-3,5-dimethyl-1-piperazinyl]carbonyl]phenyl]-;6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-{4-[(3R,5S)-3,5-dimethylpiperazine-1-carbonyl]phenyl}pyridazine-3-carboxamide;Ensartinib (X-396);X396; X-396; X 396; ENSARTINIB;;6-Amino-5-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-((3R,5S)-3,5-dimethylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide | | CAS: | 1370651-20-9 | | MF: | C26H27Cl2FN6O3 | | MW: | 561.44 | | EINECS: | | | Mol File: | 1370651-20-9.mol |  |
Ensartinib (X-396) manufacturers
- Ensartinib
-
- US $645.00-396.00 / mg
- 2025-11-10
- CAS:1370651-20-9
- Min. Order:
- Purity: 99.92%
- Supply Ability: 10g
- Ensartinib
-
- US $0.00-0.00 / mg
- 2025-07-31
- CAS:1370651-20-9
- Min. Order: 10mg
- Purity: 95%+
- Supply Ability: 10000000
|
|
1370651-20-9
Recommend Suppliers |
|